» Articles » PMID: 37221050

Geriatric Nutritional Risk Index is a Predictor of Tolerability of Antifibrotic Therapy and Mortality Risk in Patients with Idiopathic Pulmonary Fibrosis

Abstract

Background And Objective: Idiopathic pulmonary fibrosis (IPF) is characterized by progressive lung fibrosis of unknown aetiology. Epidemiological studies have suggested that IPF progression may negatively affect nutritional status. Weight loss during antifibrotic therapy is also frequently encountered. The association of nutritional status and outcome has not been fully evaluated in IPF patients.

Methods: This retrospective multicohort study assessed nutritional status of 301 IPF patients receiving antifibrotic therapy (Hamamatsu cohort, n = 151; Seirei cohort, n = 150). Nutritional status was evaluated using the Geriatric Nutritional Risk Index (GNRI). The GNRI was calculated based on body mass index and serum albumin. The relationship between nutritional status and tolerability of antifibrotic therapy as well as mortality was explored.

Results: Of 301 patients, 113 (37.5%) had malnutrition-related risk (GNRI < 98). Patients with malnutrition-related risk were older, had increased exacerbations and worse pulmonary function than those without a GNRI status <98. Malnutrition-related risk was associated with a higher incidence of discontinuation of antifibrotic therapy, particulary due to gastrointestinal disturbances. IPF patients with malnutrition-related risk (GNRI < 98) had shorter survival than those without such risk (median survival: 25.9 vs. 41.1 months, p < 0.001). In multivariate analysis, malnutrition-related risk was a prognostic indicator of antifibrotic therapy discontinuation and mortality, independent of age, sex, forced vital capacity, or gender-age-physiology index.

Conclusion: Nutritional status has significant effects on the treatment and outcome in patients with IPF. Assessment of nutritional status may provide important information for managing patients with IPF.

Citing Articles

Mortality-related risk factors of idiopathic pulmonary fibrosis: a systematic review and meta-analysis.

Sun X, Lei S, Zhao H, Guo L, Wang Y J Thorac Dis. 2025; 16(12):8338-8349.

PMID: 39831203 PMC: 11740034. DOI: 10.21037/jtd-23-1908.


Rectus femoris cross sectional area and timed up and go test potential useful of as a predictor of sarcopenia and mortality in idiopathic pulmonary fibrosis.

Fernandez-Jimenez R, Cabrera-Cesar E, Sanmartin-Sanchez A, Sanchez-Garcia A, Espildora-Hernandez F, Vegas-Aguilar I Front Nutr. 2024; 11:1440402.

PMID: 39698245 PMC: 11652176. DOI: 10.3389/fnut.2024.1440402.


The Prognostic Role of Advanced Lung Cancer Inflammation Index in Patients with Idiopathic Pulmonary Fibrosis.

Bozkus F, Keskin O J Clin Med. 2024; 13(19).

PMID: 39407934 PMC: 11477896. DOI: 10.3390/jcm13195874.


IA-Body Composition CT at T12 in Idiopathic Pulmonary Fibrosis: Diagnosing Sarcopenia and Correlating with Other Morphofunctional Assessment Techniques.

Fernandez-Jimenez R, Sanmartin-Sanchez A, Cabrera-Cesar E, Espildora-Hernandez F, Vegas-Aguilar I, Del Mar Amaya-Campos M Nutrients. 2024; 16(17).

PMID: 39275202 PMC: 11396836. DOI: 10.3390/nu16172885.


Geriatric nutritional risk index has a prognostic value for recovery outcomes in elderly patients with brain abscess.

Pei X, Zhang Y, Jiang D, Zhang M, Fu J, Niu Y Front Nutr. 2024; 11:1410483.

PMID: 39091681 PMC: 11291442. DOI: 10.3389/fnut.2024.1410483.